Belviq Cancer Lawsuit Attorney
Dubo Law is evaluating claims from potential plaintiffs who were diagnosed with cancer after taking Belviq, Belviq XR, or another brand of lorcaserin.
The Belviq Litigation: A Primer
Belviq (generic name lorcaserin) is a popular prescription weight-loss product developed by Eisai Inc. It is designed to aid anyone experiencing obesity and weight-related health issues. Specifically, it operates to curb hunger in those taking the drug.
Shockingly, a United States Food and Drug Administration (FDA) safety trial determined that the product could significantly increase the risk of developing different types of cancer that attack the lungs, pancreas, or colon. As a consequence, the FDA issued a full recall of Belviq in February 2020.
Belviq: What are the Risks?
Unfortunately, weight-loss drugs are not exactly highly regarded for their safety, and Belviq is no exception to that rule. In a five-year, double-blind study of over 10,000 patients, individuals using Belviq were more likely to develop cancer than those who took a placebo. The FDA states that a broad range of cancer types was reported, while certain forms were occurring more frequently in people taking lorcaserin. For example:
- Pancreatic cancer
- Colorectal cancer
- Lung cancer
A drug like this one should never have been available on the market. And their manufacturers should be held accountable. Those suffering from cancer caused by Belviq are entitled to full and fair compensation.
Your Fight for Justice is Our Fight
If you or your loved one used Belviq and was diagnosed with cancer, you might be eligible for compensation for medical expenses, lost income, and emotional distress. Dubo Law will fight to ensure that you receive the compensation to which you are entitled, so don’t hesitate in contacting us today at (443) 275-6345.
Should I Stop Taking Belviq?
Anyone taking Belviq should stop and consult with a healthcare professional about possible safer options or alternatives.
Has Belviq been recalled by the FDA?
Yes. The FDA requested a product recall in February 2020, and it forced Eisai to remove all Belviq and Belviq XR products from the market. Since that time, Eisai has complied with the FDA’s request.
Who Is Eligible for a Belviq Lawsuit?
Anyone who took Belviq or its generic equivalent and was diagnosed with cancer upon that might be eligible to pursue a claim against the drug’s manufacturer. Specifically, if you meet any of the following requirements, you may have a case:
- You’re 18 or older
- You’ve been diagnosed with cancer after you’ve taken Belviq, Belviq XR, or another lorcaserin brand
- If your loved one took this drug to resolve weight-related problems and was diagnosed with cancer, you may contact us on their behalf
What Damages Can I Recover in a Belviq Claim?
If you successfully file a drug or medical device claim, you have the opportunity to receive compensation for some or all of the following damages:
- Past and future medical bills, including medication, in-home or hospital care
- Lost income
- Lost future wages or income
- Pain and suffering
- Funeral expenses or other post-mortem costs associated with a loved one.
A plaintiff may be eligible for compensation for any past or future expenses linked with their cancer diagnosis.
Contact Us for Your Free Case Review!
Hours of Operation
Monday – Friday: 8:30 AM – 5:00 PM
Your health and safety are important to us. Please be advised that we are open for business during COVID-19 quarantines. All consultations will be conducted either via video chat, phone, or email.